CREBBP and diffuse large B-cell lymphoma: Moreover, orthotopic xenografts established intravenously using the same human DLBCL cells with wild-type or heterozygous-mutant CREBBP showed a greater capacity for engraftment in the bone marrow of both immunocompromised mice and mice with a humanized immune system.